Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - INTEREST INCOME & EXPENSE
Interest Income & Expense GERN - Geron Corporation
8.31 M
LAST VALUE
49.08%
2 YEAR CAGR
0.00%
5 YEAR CAGR
64.87%
10 YEAR CAGR